US drug bill controversy could slow device user fee passage
This article was originally published in Clinica
Executive Summary
Efforts to make sweeping US Food and Drug Administration (FDA) reforms may delay passage of a drug and medical device user fee bill the US industry is counting on this year, unless members of Congress restrain themselves.